SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-021086
Filing Date
2021-11-02
Accepted
2021-11-02 07:16:52
Documents
14
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20211102.htm   iXBRL 8-K 34062
2 EX-99.1 espr8-kex991q32021.htm EX-99.1 77364
6 tm2026634d1_ex99-1img001a01a.jpg GRAPHIC 5932
  Complete submission text file 0001628280-21-021086.txt   269809

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20211102.xsd EX-101.SCH 1927
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20211102_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20211102_pre.xml EX-101.PRE 13202
7 EXTRACTED XBRL INSTANCE DOCUMENT espr-20211102_htm.xml XML 10983
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 211369249
SIC: 2834 Pharmaceutical Preparations